Costs of haematological disease high and rising
- PMID: 27476782
- DOI: 10.1016/S2352-3026(16)30074-6
Costs of haematological disease high and rising
Comment in
-
Health-care use drives the economic burden of blood disorders in Europe.Lancet Haematol. 2016 Aug;3(8):e355-6. doi: 10.1016/S2352-3026(16)30077-1. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476783 No abstract available.
Comment on
-
Health-care use drives the economic burden of blood disorders in Europe.Lancet Haematol. 2016 Aug;3(8):e355-6. doi: 10.1016/S2352-3026(16)30077-1. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476783 No abstract available.
-
Economic burden of malignant blood disorders across Europe: a population-based cost analysis.Lancet Haematol. 2016 Aug;3(8):e362-70. doi: 10.1016/S2352-3026(16)30062-X. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476787
-
Economic burden of non-malignant blood disorders across Europe: a population-based cost study.Lancet Haematol. 2016 Aug;3(8):e371-8. doi: 10.1016/S2352-3026(16)30061-8. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476788
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical